
Integrilin Injection
Marketer
Merck Ltd
Salt Composition
Eptifibatide (0.75mg/ml)
Overview Integrilin Injection
Eptifibatide injection is an antithrombotic agent that inhibits the formation of dangerous blood clots. It's employed in acute myocardial infarction treatment and to prevent thrombus formation during percutaneous coronary intervention (PCI) to restore coronary blood flow. Administration is strictly under medical supervision, with dosage and treatment length determined by your physician. Continue all other prescribed medications as directed, even following the injection. A potential side effect is thrombocytopenia, increasing bleeding risk; report any petechiae or blood in your excretions immediately. Hypotension is another possible adverse effect. Your doctor will discuss the benefits and risks before treatment. Caution is advised for certain patients. Before receiving this injection, disclose any bleeding disorders, hepatic or renal impairments, pregnancy, breastfeeding, and all other medications you are currently using.
Uses of Integrilin Injection
Thrombosis prophylaxis | Myocardial infarction prevention
Major Benefits of Integrilin Injection:
This medication will be administered by your healthcare provider. Self-medication is not recommended.
Common Side effects of Integrilin Injection:
- Bleeding
- Decreased blood pressure
How to use Integrilin Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Integrilin Injection works:
Eptifibatide injection inhibits platelet aggregation, thus reducing the risk of dangerous thrombus development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Integrilin Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Integrilin Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human trials are scarce.
Breast feedingCAUTION
The use of Integrilin Injection while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingNOT RELEVANT
Integrilin Injection is solely for inpatient administration.
KidneyCAUTION
For individuals with kidney impairment, Integrilin Injection requires careful administration and may necessitate dosage modification. Physician consultation is advised. Integrilin Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding Integrilin Injection use in patients with hepatic impairment is scarce. Physician consultation is advised. Integrilin Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Integrilin Injection :
Omit a dose of Integrilin Injection? Seek your physician's advice.
Facts to Know About Integrilin Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide and amino acid analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | IIb/IIIa receptor antagonists |
